The effect of extended aromatase inhibition on the adapted overall survival was not statistically significantly different between patients with tumours expressing both the oestrogen and progesterone receptor and patients with tumours expressing only one hormone receptor (p interaction = 0.051) (Supplementary Fig. S1). Here, CYP19A1 is linked to neoplasm.